December 2016 FDA Recall Drug by Vintage Pharmaceuticals Llc, Dba Qualitest Pharmaceuticals
D-0326-2017 - Failed Stability Specifications

This Class III drug recall was voluntarily initiated by Vintage Pharmaceuticals Llc, Dba Qualitest Pharmaceuticals on December 22, 2016 for the product Drug. The FDA reported the reason for recall as failed stability specifications. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0326-2017

Reason for Recall
Failed Stability Specifications
Initiated
12-22-2016
Reported
01-11-2017
Quantity
1200 bottles

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
76087
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vintage Pharmaceuticals LLC, DBA Qualitest Pharmaceuticals
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide
Termination Date About Termination Date
Date that FDA officially terminated the recall.
09-18-2017
Product Description About Product Description
Full technical description of the product.
TEMAZEPAM CAPSULES USP, 7.5 mg, 100 count bottles, Rx only, Manufactured for: QUALITEST PHARMACEUTICALS, HUNTSVILLE, AL 35811, NDC 0603-5891-21

Batch or Lot Expiration Information

Lot# T248H15A, Exp. 08/17